FundedJobs.

Series C+ · Raised $182M · Aug 8, 2026announcement ↗

LifeMine Therapeutics

Backed by

Milky Way Investments

BiotechWatertown, Massachusettslifeminetx.com ↗

Careers →Visit website ↗

What they do

LifeMine Therapeutics is a clinical-stage biopharmaceutical company using evolutionary insights from fungi, human genomics, and data-intensive discovery to develop precision medicines. Its lead program, LIFE-001, is being developed for organ transplant rejection prevention and potential immune-mediated disorders, serving patients in transplantation and immunology.

Hiring outlook

A $182 million Series C+ round suggests expansion of clinical development, clinical operations, regulatory, pharmacology, and CMC teams as LIFE-001 advances through trials. The company may also add drug-discovery, data science, engineering, and program-management roles to support its platform and pipeline.

Open roles (1)